These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6257468)

  • 1. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
    Doerr HW; Geisen HP; Kapp M; Schmidt W
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1316-20. PubMed ID: 6257468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
    Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
    J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
    Wolff MH; Marklein G; Schneweis KE; Stifter G
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
    Müller G; Baumann H
    Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of rubella virus infections.
    Iwakata S; Rhodes AH; Labzoffsky NA
    Can Med Assoc J; 1973 Apr; 108(7):894-5 passim. PubMed ID: 4581796
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of rubella prevention in Austria (1988 status)].
    Hofmann H; Kunz C
    Wien Med Wochenschr; 1989 Jul; 139(14):330-3. PubMed ID: 2773490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rubella embryopathy, still now? (author's transl)].
    Enders G
    Geburtshilfe Frauenheilkd; 1982 May; 42(5):403-13. PubMed ID: 6921121
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guide to the management of rubella problems.
    Middleton PJ; Larke RP; Lessard P; Doran TA
    Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of rubella vaccination in the puerperium].
    Huter O; Ortner A
    Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):640-2. PubMed ID: 3770413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rubella antibody in a sample of Foggia (Italy) population (author's transl)].
    Telesforo P; D'Errico A; Rosenberg R
    Ann Sclavo; 1979; 21(4):413-8. PubMed ID: 554544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics of infection with toxoplasma gondii, rubella-, mumps- and cytomegalovirus (author's transl)].
    Berger J
    Zentralbl Bakteriol Orig A; 1973 Oct; 224(4):503-22. PubMed ID: 4150118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence and prevalence of antibodies to measles, herpesvirus infections, mumps and rubella in the cerebrospinal fluid and serum of subjects with demyelinating diseases of the central nervous system].
    Nicoletti F; Falsaperla A; Castro A; Pennisi G
    Boll Soc Ital Biol Sper; 1978 Jan; 54(1):5-11. PubMed ID: 216380
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.